How has been the historical performance of Vaishali Pharma?

Answer:The historical performance of Vaishali Pharma shows significant fluctuations in key financial metrics over the years. Breakdown: Vaishali Pharma's net sales have shown a steady increase from INR 52.31 crore in March 2021 to INR 99.03 crore in March 2025, with a notable jump from INR 69.66 crore in March 2023 to INR 86.28 crore in March 2024. However, the total operating income peaked at INR 11.35 crore in March 2023 but dropped to INR 3.31 crore by March 2025. The operating profit margin, which was at 13.09% in March 2023, fell drastically to 0.1% in March 2025. Profit before tax also reflected this trend, decreasing from INR 8.85 crore in March 2023 to INR 1.23 crore in March 2025. Profit after tax followed a similar pattern, declining from INR 6.60 crore in March 2023 to INR 0.82 crore in March 2025. The company's total liabilities increased from INR 66.08 crore in March 2020 to INR 109.66 crore in March 2025, while total assets rose from INR 66.08 crore to INR 109.66 crore in the same period. Cash flow from operating activities turned negative in March 2025 at -INR 18 crore, contrasting with positive cash flows in previous years. Overall, Vaishali Pharma's financial performance indicates a challenging environment, particularly in profitability and cash flow management.